Connecticut General Life Insurance Company and Cigna Health and Life Insurance Company v. Biohealth Laboratories, Inc., PB Laboratories, LLC, Epic Reference Labs, Inc., Epinex Diagnostics, Inc., NJ Reference Laboratories, Inc., and Alethea Laboratories, Inc.; Epic Reference Labs, Inc., Biohealth Medical Laboratory, Inc., and PB Laboratories, LLC v. Connecticut General Life Insurance Company and Cigna Health and Life Insurance Company

CourtDistrict Court, D. Connecticut
DecidedJune 15, 2026
Docket3:19-cv-01326
StatusUnknown

This text of Connecticut General Life Insurance Company and Cigna Health and Life Insurance Company v. Biohealth Laboratories, Inc., PB Laboratories, LLC, Epic Reference Labs, Inc., Epinex Diagnostics, Inc., NJ Reference Laboratories, Inc., and Alethea Laboratories, Inc.; Epic Reference Labs, Inc., Biohealth Medical Laboratory, Inc., and PB Laboratories, LLC v. Connecticut General Life Insurance Company and Cigna Health and Life Insurance Company (Connecticut General Life Insurance Company and Cigna Health and Life Insurance Company v. Biohealth Laboratories, Inc., PB Laboratories, LLC, Epic Reference Labs, Inc., Epinex Diagnostics, Inc., NJ Reference Laboratories, Inc., and Alethea Laboratories, Inc.; Epic Reference Labs, Inc., Biohealth Medical Laboratory, Inc., and PB Laboratories, LLC v. Connecticut General Life Insurance Company and Cigna Health and Life Insurance Company) is published on Counsel Stack Legal Research, covering District Court, D. Connecticut primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Connecticut General Life Insurance Company and Cigna Health and Life Insurance Company v. Biohealth Laboratories, Inc., PB Laboratories, LLC, Epic Reference Labs, Inc., Epinex Diagnostics, Inc., NJ Reference Laboratories, Inc., and Alethea Laboratories, Inc.; Epic Reference Labs, Inc., Biohealth Medical Laboratory, Inc., and PB Laboratories, LLC v. Connecticut General Life Insurance Company and Cigna Health and Life Insurance Company, (D. Conn. 2026).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF CONNECTICUT

SRS ESRC eRe Rincon eee □□□ CONNECTICUT GENERAL LIFE : INSURANCE COMPANY and CIGNA ; HEALTH AND LIFE INSURANCE : COMPANY, : Plaintiffs, : V. : Civil No. 3:19-cv-01324 (JCH) BIOHEALTH LABORATORIES, INC., PB : June 15, 2026 LABORATORIES, LLC, EPIC REFERENCE: LABS, INC., EPINEX DIAGNOSTICS, INC., : NJ REFERENCE LABORATORIES, INC., : and ALETHEA LABORATORIES, INC., Defendants. : Af A StS A OP SY Yt tt StS YA SSE et St tH tS xX

Se a an SE OS SE ES OE SS SO SS OS SS SS A SS SS Sm x EPIC REFERENCE LABS, INC., : BIOHEALTH MEDICAL LABORATORY, ; INC., and PB LABORATORIES, LLC, : Plaintiffs, : : Civil No. 3:19-cv-1326 (JCH) CONNECTICUT GENERAL LIFE June 15, 2026 INSURANCE COMPANY and CIGNA : HEALTH AND LIFE INSURANCE COMPANY, : Defendants. : rt nr At nS ty ft ED nn St SSF At SAH SH HS HS x REPORT OF SPECIAL MASTER

I. INTRODUCTION This is the report of a special master appointed by order of the court pursuant to Rule 53 of the Federal Rules of Civil Procedure (the “Order”) (ECF Doc. Nos. 533, 190).! The Order directs that the special master review each document listed on a privilege log, in both redacted and unredacted form, to determine whether privilege was properly asserted and write a report detailing the findings. There were 953 documents (1906 in both forms) listed on the privilege log. This is the report required by the Order. The report is in two parts. This memorandum summarizes the factual background, the legal basis for the analysis of the privilege claims and briefly describes the conclusions of that analysis. The second part is a separate form for each document in redacted and unredacted form that describes the document, the privilege claim(s), an analysis of the claim and a conclusion as to whether the claim was properly asserted for that document. Il. BACKGROUND This report is applicable to two cases. Both cases were filed in this court in August of 2019. The cases involve the same parties: Connecticut General Life Insurance Company and Cigna Health and Life Insurance Company (hereinafter collectively referred to as “Cigna”) on one side and BioHealth Laboratories, Inc. (“BioHealth”), PB Laboratories, LLC (“PB Labs”), and Epic Reference Labs, Inc. (“Epic’) (hereinafter collectively referred to as “the Labs”) on the other side.

! Unless otherwise indicated, references to ECF document numbers refer to the same document filed in Civil No. 3:19-cv-01324 (JCH), then Civil No. 3:19-cv-1326 (JCH), respectively. For example, ECF No. 533 is the Order of Appointment of Special Master filed in Civil No. 3:19-cv-01324 (JCH), whereas ECF No. 190 refers to the Order of Appointment of Special Master filed in Civil No. 3:19-cv-1326 (JCH).

After early motions, the cases were consolidated for discovery and were subsequently consolidated for trial. The cases involved competing claims for payments for biological tests performed by the Labs. The Labs rendered invoices for the tests. Cigna paid some, but not all of the invoices. Cigna sought to recover for the invoices it paid, generally on the grounds of misrepresentation. The Labs sought payment for their unpaid invoices. For a detailed description of these cases, see the court’s ruling on summary judgment. Connecticut Gen. Life Ins. Co. v. BioHealth Laboratories, Inc., No. 3:19-CV-01324 (JCH), 2024 WL 2106837 (D. Conn, Mar. 1, 2024). See also, the Order for Response and Order to Show Cause dated March 7, 2025, ECF Doc. Nos. 523, 180 (“Order to Show Cause”). Following a twelve-day trial, two verdicts were returned by the jury on November 4, 2024. See ECF Doc. Nos. 483, 108. Cigna was awarded damages. The Labs’ claims against Cigna were denied. During discovery Cigna withheld and redacted documents. Cigna claimed they were protected by the attorney-client and work product privileges. Cigna produced a privilege log to the Labs. It was produced in four tranches over fifteen months. The last and largest part of its privilege log was delivered to the Labs after fact discovery was closed, and approximately two months before the dispositive motion deadline. Below is a description of the size and delivery date of each of the four parts of Cigna’s privilege log.

The Privilege Log and its three supplements, as produced to the Labs, are hereinafter referred to collectively as the “Privilege Log.” Of the 953 documents listed on the Privilege Log, approximately 878, over 90%, are dated in 2014 and 2015. At that time, Cigna had a large in-house legal staff, including an in- house Litigation Department. By letter dated May 22, 2025, Cigna provided a list of nine in- house attorneys “who are either listed in Cigna’s privilege logs or may appear on privileged documents.”

Two of Cigna’s in-house attorneys played significant roles in these cases, William M. Welch II (“Mr. Welch’) and Michael Goldfarb (“Mr. Goldfarb”).

Mr. Welch was employed by Cigna as Associate Chief Counsel from April 2012 until August 2016. He was the attorney most actively involved in the investigation of the Labs’ claims and communicated directly with their attorneys. The Order to Show Cause notes that Mr. Welch’s name appears on the Privilege Log over 300 times (Order to Show Cause, p. 4).

Mr. Goldfarb was less involved. He did not join Cigna’s litigation department until May 2015 and worked in business capacities after December 2016. His name appears 46 times on Cigna’s Privilege Log.

Together, Mr. Welch and Mr. Goldfarb were the basis for Cigna’s assertion of privilege. (Order to Show Cause, p. 4). They both testified at the trial as fact witnesses on behalf of Cigna.

During the trial, the Labs questioned whether the testimony of the two Cigna attorneys waived Cigna’s attorney-client privilege and “whether prior assertion of privilege had prejudiced their ability to cross examine Mr. Goldfarb and Mr. Welch.” Order to Show Cause at 5. The court instructed the Labs to address that issue, as they saw fit, in post-trial motions. Id.

On December 4, 2024, the Labs filed a motion to compel and for sanctions. See ECF Doc. Nos. 510, 139. The court ordered Cigna to produce a designated sample of documents on the Privilege Log for in camera review. See ECF Doc. Nos. 516, 177. Following its in camera review, the court made the following findings: The court conducted a thorough review of the sample of documents that Cigna provided to the court in camera. For a majority of the documents where Cigna asserted privilege, the court finds the assertion to be overbroad or outright inappropriate. In certain cases, documents were withheld in their entirety when light redactions would have been appropriate. In a large number of cases, it appeared to the court that Cigna reflexively redacted or withheld any communication involving a lawyer, without attempting to discern whether the predominant purpose of the communication was to seek or provide legal advice. In several instances, for example, the court noted that documents were withheld in their entirety because lawyers appeared on an email chain. For example, the document listed on Cigna’s privilege logs at Bates number CIGNA 19-1326-0327206, listed on page 80 of Cigna’s fourth privilege log [or third supplemental privilege log], is an email message to a large list of recipients within Cigna, a few of whom are Cigna lawyers. Without discussing the content of this communication, the court can discern no giving or seeking legal advice whatsoever. However, the document was withheld in its entirety, on the basis that it was a “privileged and confidential communication between Cigna employees and Cigna in-house counsel seeking legal advice regarding [a] potential policy change.” Order to Show Cause at 7.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Upjohn Co. v. United States
449 U.S. 383 (Supreme Court, 1981)
United States v. Harry Neil Kelly
569 F.2d 928 (Fifth Circuit, 1978)
In Re Grand Jury Subpoena
599 F.2d 504 (Second Circuit, 1979)
Bulow v. Bulow
811 F.2d 136 (Second Circuit, 1987)
Leslie Ray Cox R.M. Cox Larry Driver Barry Nichols John Bullard Robert W. Kennedy, Jr. Lorenzo G. East Clarence M. Pope, Jr. C.R. Altes Jack E. Merrymon Terry P. West R.S. Arnold M.W. Milstead J.W. Wade Manning A.C. Snider Terry H. Melvin Thomas E. Hill Gary D. Swann Ronald E. Frazier Anthony J. Crapet Robert M. Green Heath L. McMeans III Billy Carter Joe A. Knight, George Boglin, Wardell Clark, Phillip L. Drummond, Don L. Flurry, Dennis R. Fulton, Dennis E. Jones, W.T. Mayberry, James R. Miller, Willie J. Nation, Oscar Lee Perry, Robert Poole, Brack Wells, Willie Young, Harry S. Turner v. Administrator United States Steel & Carnegie and United States Steel & Carnegie Pension Fund, United Steelworkers of America, Afl-Cio-Clc and Usx Corporation, A/K/A United States Steel Corporation, Leslie Ray Cox, R.M. Cox, Larry Driver, Barry Nichols, John Bullard, Robert W. Kennedy, Jr., Lorenzo G. East, Clarence M. Pope, C.R. Altes, Jack E. Merrymon, Terry P. West, R.S. Arnold, M.W. Milstead, J.W. Wade, A.C. Snider, Terry H. Melvin, Thomas E. Hill, Gary D. Swann, Ronald E. Frazier, Anthony J. Crapet, Robert M. Green, Heath L. McMeans Iii, Billy Carter, Joe A. Knight, George Boglin, Wardell Clark, Phillip L. Drummond, Don L. Flurry, Dennis R. Fulton, Dennis E. Jones, W.T. Mayberry, James R. Miller, Willie J. Nation, Oscar Lee Perry, Robert Poole, Brack Wells, Willie Young, Harry S. Turner v. Administrator United States Steel & Carnegie, United States Steel & Carnegie Pension Fund, Usx Corporation, A/K/A United States Steel Corporation
17 F.3d 1386 (Eleventh Circuit, 1994)
Southern Bell Tel. & Tel. Co. v. Deason
632 So. 2d 1377 (Supreme Court of Florida, 1994)

Cite This Page — Counsel Stack

Bluebook (online)
Connecticut General Life Insurance Company and Cigna Health and Life Insurance Company v. Biohealth Laboratories, Inc., PB Laboratories, LLC, Epic Reference Labs, Inc., Epinex Diagnostics, Inc., NJ Reference Laboratories, Inc., and Alethea Laboratories, Inc.; Epic Reference Labs, Inc., Biohealth Medical Laboratory, Inc., and PB Laboratories, LLC v. Connecticut General Life Insurance Company and Cigna Health and Life Insurance Company, Counsel Stack Legal Research, https://law.counselstack.com/opinion/connecticut-general-life-insurance-company-and-cigna-health-and-life-ctd-2026.